Millennium Pharmacon International (SDPC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.063x

Based on the latest financial reports, Millennium Pharmacon International (SDPC) has a cash flow conversion efficiency ratio of -0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.67 Billion ≈ $-1.09 Million USD) by net assets (Rp296.69 Billion ≈ $17.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Millennium Pharmacon International defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Millennium Pharmacon International - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Millennium Pharmacon International's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Millennium Pharmacon International Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Millennium Pharmacon International ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Vo2 Cap Holding AB ST:VO2	-0.002x
Energys Group Limited Ordinary Shares NASDAQ:ENGS	N/A
Crown Lifters Limited NSE:CROWN	0.022x
QPR Software Oyj HE:QPR1V	-0.282x
BTC Health Ltd AU:BTC	-0.023x
Soder Sportfiske AB ST:SODER	0.054x
Metro Bank PLC LSE:MTRO	0.026x
Ecoscience International Berhad KLSE:0255	0.088x

Annual Cash Flow Conversion Efficiency for Millennium Pharmacon International (2004–2024)

The table below shows the annual cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Millennium Pharmacon International (SDPC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp282.50 Billion ≈ $16.55 Million	Rp-125.45 Billion ≈ $-7.35 Million	-0.444x	-34.56%
2023-12-31	Rp277.71 Billion ≈ $16.27 Million	Rp-91.65 Billion ≈ $-5.37 Million	-0.330x	-308.43%
2022-12-31	Rp258.91 Billion ≈ $15.17 Million	Rp41.00 Billion ≈ $2.40 Million	0.158x	+306.44%
2021-12-31	Rp236.98 Billion ≈ $13.89 Million	Rp-18.18 Billion ≈ $-1.07 Million	-0.077x	-124.52%
2020-12-31	Rp229.20 Billion ≈ $13.43 Million	Rp71.69 Billion ≈ $4.20 Million	0.313x	+391.54%
2019-12-31	Rp235.44 Billion ≈ $13.80 Million	Rp-25.26 Billion ≈ $-1.48 Million	-0.107x	-627.27%
2018-12-31	Rp232.11 Billion ≈ $13.60 Million	Rp4.72 Billion ≈ $276.75K	0.020x	-2.94%
2017-12-31	Rp212.61 Billion ≈ $12.46 Million	Rp4.46 Billion ≈ $261.18K	0.021x	+111.13%
2016-12-31	Rp143.28 Billion ≈ $8.40 Million	Rp-26.99 Billion ≈ $-1.58 Million	-0.188x	+63.20%
2015-12-31	Rp134.31 Billion ≈ $7.87 Million	Rp-68.74 Billion ≈ $-4.03 Million	-0.512x	-1218.86%
2014-12-31	Rp121.79 Billion ≈ $7.14 Million	Rp-4.73 Billion ≈ $-276.93K	-0.039x	+91.69%
2013-12-31	Rp114.87 Billion ≈ $6.73 Million	Rp-53.67 Billion ≈ $-3.14 Million	-0.467x	-2326.94%
2012-12-31	Rp104.62 Billion ≈ $6.13 Million	Rp2.19 Billion ≈ $128.61K	0.021x	+118.58%
2011-12-31	Rp94.78 Billion ≈ $5.55 Million	Rp-10.70 Billion ≈ $-626.92K	-0.113x	-273.40%
2007-12-31	Rp70.24 Billion ≈ $4.12 Million	Rp4.57 Billion ≈ $267.94K	0.065x	+391.77%
2006-12-31	Rp60.63 Billion ≈ $3.55 Million	Rp802.62 Million ≈ $47.03K	0.013x	-78.04%
2004-12-31	Rp45.18 Billion ≈ $2.65 Million	Rp2.72 Billion ≈ $159.57K	0.060x	--

About Millennium Pharmacon International

JK:SDPC Indonesia Medical Distribution

Market Cap

$13.66 Million

Rp233.14 Billion IDR

Market Cap Rank

#26256 Global

#572 in Indonesia

Share Price

Rp183.00

Change (1 day)

+5.78%

52-Week Range

Rp125.00 - Rp202.00

All Time High

Rp357.65